menu search

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trials SAN DIEGO and LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, today announced a partnership […] The post Conduit Pharmaceuticals Partners with ClinConnect on Co... Read More
Posted: Oct 11 2023, 12:30
Author Name: forextv
Views: 082635

Search within

Pages Search Results: